Source: FinanzNachrichten

Masters Sp: Masters Speciality Pharma Announces Launch of Neuropad in Brazil for Detection of Diabetic Foot Syndrome

ELSTREE, England, Oct. 30, 2019 /PRNewswire/ -- Masters Speciality Pharma ("Masters"), a UK-headquartered pharmaceutical company specialising in the global distribution of high-quality, life-chang...

Read full article »
Est. Annual Revenue
$25-100M
Est. Employees
25-100
Zulf Masters's photo - Founder & CEO of Masters Speciality Pharma

Founder & CEO

Zulf Masters

CEO Approval Rating

90/100